This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Source of effectiveness data
Effectiveness data was derived from a single study.
Link between effectiveness and cost data
Costing was undertaken on the same patient sample as that used in the effectiveness analysis, prospectively for the pathway group and retrospectively for the pre-pathway group.
Study sample
In total, 45 patients were included in the study. The clinical pathway was implemented for 15 patients, while the other 30 patients were treated without the implementation of the pathway guidelines. The pre-pathway and pathway groups were comparable with regard to patients' demographic characteristics, disease stage and payer mix. Patients who required flap reconstruction as part of the surgical procedure were not included in the study. Power calculations relating to the sample size were not performed.
